| Literature DB >> 28744191 |
Anne L Høyland1,2, Geir Øgrim3,4, Stian Lydersen1, Sigrun Hope5,6, Morten Engstrøm7,8, Tonje Torske9, Terje Nærland5,10, Ole A Andreassen5,11.
Abstract
Executive functions are often affected in autism spectrum disorders (ASD). The underlying biology is however not well known. In the DSM-5, ASD is characterized by difficulties in two domains: Social Interaction and Repetitive and Restricted Behavior, RRB. Insistence of Sameness is part of RRB and has been reported related to executive functions. We aimed to identify differences between ASD and typically developing (TD) adolescents in Event Related Potentials (ERPs) associated with response preparation, conflict monitoring and response inhibition using a cued Go-NoGo paradigm. We also studied the effect of age and emotional content of paradigm related to these ERPs. We investigated 49 individuals with ASD and 49 TD aged 12-21 years, split into two groups below (young) and above (old) 16 years of age. ASD characteristics were quantified by the Social Communication Questionnaire (SCQ) and executive functions were assessed with the Behavior Rating Inventory of Executive Function (BRIEF), both parent-rated. Behavioral performance and ERPs were recorded during a cued visual Go-NoGo task which included neutral pictures (VCPT) and pictures of emotional faces (ECPT). The amplitudes of ERPs associated with response preparation, conflict monitoring, and response inhibition were analyzed. The ASD group showed markedly higher scores than TD in both SCQ and BRIEF. Behavioral data showed no case-control differences in either the VCPT or ECPT in the whole group. While there were no significant case-control differences in ERPs from the combined VCPT and ECPT in the whole sample, the Contingent Negative Variation (CNV) was significantly enhanced in the old ASD group (p = 0.017). When excluding ASD with comorbid ADHD we found a significantly increased N2 NoGo (p = 0.016) and N2-effect (p = 0.023) for the whole group. We found no case-control differences in the P3-components. Our findings suggest increased response preparation in adolescents with ASD older than 16 years and enhanced conflict monitoring in ASD without comorbid ADHD during a Go-NoGo task. The current findings may be related to Insistence of Sameness in ASD. The pathophysiological underpinnings of executive dysfunction should be further investigated to learn more about how this phenomenon is related to core characteristics of ASD.Entities:
Keywords: ASD; CNV; ERP; Go-NoGo task; N2; P3; executive functions; insistence of sameness
Year: 2017 PMID: 28744191 PMCID: PMC5504259 DOI: 10.3389/fnins.2017.00393
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Demographics; number (n) and mean ± SD.
| Male | 31 | 36 | ||
| Female | 18 | 13 | ||
| Infantile autism | 13 | |||
| Asperger disorder | 18 | |||
| PDD NOS | 18 | |||
| All | 49 | 15.6 ± 1.8 | 49 | 15.6 ± 2.4 |
| <16 years | 27 | 14.3 ± 1.0 | 26 | 13.7 ± 1.3 |
| ≥16 years | 22 | 17.3 ± 1.1 | 23 | 17.8 ± 1.3 |
| 49 | ||||
| Full scale IQ | 36 | 91.9 ± 17.7 | ||
| Verbal IQ | 47 | 87.6 ± 19.0 | ||
| Nonverbal IQ | 48 | 98.1 ± 19.3 | ||
| 47 | 1.9 ± 2.3 | 49 | 18.7 ± 6.7 | |
| Infantile autism | 13 | 19.7 ± 6.0 | ||
| Asperger disorder | 18 | 17.7 ± 6.9 | ||
| PDD NOS | 18 | 19.0 ± 7.1 | ||
| 36 | 42.0 ± 6.0 | 37 | 67.6 ± 10.2 | |
| <16 years | 23 | 41.9 ± 6.4 | 22 | 64.8 ± 8.9 |
| ≥16 years | 13 | 42.2 ± 5.4 | 15 | 71.6 ± 10.8 |
SCQ, Social Communication Questionnaire; BRIEF, Brief Rating Inventory of Executive Function; GEC, Global Executive Composite score; PDD NOS, Pervasive Developmental Disorder Not Otherwise Specified.
Electrophysiological measures, ERPs.
| Cue P3 | Maximum positive peak in Pz 260–360 ms after S1 |
| CNV | Averaged amplitude in Cz 1,000–1,100 ms after S1(immediately before S2) |
| N2 Go/ NoGo | Maximum negative amplitude in Fz 90–290 ms after stimuli 2 |
| P3 Go | Maximum positive peak in Pz 260–360 ms after S2 |
| P3 NoGo | Maximum positive peak in Cz 270–420 ms after S2 |
Figure 1Amplitude voltage map [in μvolts (μV)] at peak latency in Go and NoGo trials. The cued Go NoGo task elicits a maximum Go P3-component after 308 ms when stimulus 2 is target (Go condition) and a NoGo P3-component after 338 ms when stimulus 2 is non-target. Observe the topography of the P3, with a maximum at more parietal site in Go condition and centrally in NoGo condition.
Figure 2Event Related Potentials, ERPs, VCPT adolescents 16 years and older.
Event Related Potentials, ERPs, in VCPT and ECPT, for TD, ASD, and ASD without comorbid ADHD (ASD–ADHD).
| CNV | All | −1.86 ± 1.2 | −1.96 ± 1.5 | −2.05 ± 1.6 | −2.12 ± 1.4 | −2.20 ± 1.8 | −2.33 ± 1.73 |
| <16 years | −2.08 ± 1.3 | −1.53 ± 1.6 | −1.33 ± 1.6 | −2.24 ± 1.4 | −1.74 ± 1.9 | −1.56 ± 2.0 | |
| ≥16 years | −1.59 ± 1.0 | −2.43 ± 1.2 | −2.59 ± 1.2 | −1.97 ± 1.3 | −2.72 ± 1.5 | −2.90 ± 1.3 | |
| N2 Go | All | −4.97 ± 2.7 | −4.07 ± 2.9 | −4.42 ± 2.8 | −2.96 ± 2.3 | −2.79 ± 3.2 | −3.61 ± 3.1 |
| <16 years | −5.90 ± 2.0 | −4.63 ± 3.1 | −5.55 ± 2.6 | −3.57 ± 2.0 | −3.45 ± 3.3 | −5.11 ± 2.5 | |
| ≥16 years | −3.83 ± 3.0 | −3.43 ± 2.6 | −3.43 ± 2.4 | −2.21 ± 2.5 | −2.05 ± 2.9 | −2.29 ± 3.1 | |
| N2 NoGo | All | −9.13 ± 3.3 | −8.74 ± 3.9 | −9.86 ± 3.3 | −4.98 ± 2.6 | −5.21 ± 4.0 | −6.52 ± 4.1 |
| <16 years | −10.57 ± 2.7 | −8.85 ± 4.7 | −10.98 ± 3.9 | −5.15 ± 2.6 | −5.24 ± 4.9 | −7.63 ± 4.8 | |
| ≥16 years | −7.35 ± 3.3 | −8.60 ± 2.9 | −8.88 ± 2.3 | −4.77 ± 2.6 | −5.17 ± 2.9 | −5.54 ± 3.1 | |
| N2-effect | All | 4.15 ± 2.6 | 4.67 ± 3.2 | 5.44 ± 2.8 | 2.02 ± 2.2 | 2.42 ± 3.1 | 2.90 ± 3.5 |
| <16 years | 4.67 ± 2.9 | 4.23 ± 3.0 | 5.43 ± 2.6 | 1.58 ± 1.9 | 1.80 ± 3.3 | 2.51 ± 4.0 | |
| ≥16 years | 3.52 ± 2.1 | 5.17 ± 3.3 | 5.44 ± 3.1 | 2.56 ± 2.4 | 3.13 ± 2.7 | 3.24 ± 3.1 | |
| Cue P3 | All | 5.46 ± 2.7 | 5.66 ± 3.0 | 5.27 ± 2.4 | 4.56 ± 2.2 | 5.26 ± 2.9 | 5.05 ± 2.08 |
| <16 years | 6.09 ± 2.4 | 5.92 ± 3.1 | 5.55 ± 2.8 | 5.05 ± 2.2 | 5.87 ± 3.1 | 6.03 ± 3.1 | |
| ≥16 years | 4.69 ± 2.8 | 5.37 ± 2.9 | 5.03 ± 2.0 | 3.97 ± 2.1 | 4.56 ± 2.5 | 4.19 ± 2.3 | |
| P3 Go | All | 9.24 ± 4.1 | 9.36 ± 3.0 | 9.60 ± 2.9 | 8.24 ± 2.9 | 8.80 ± 4.3 | 9.47 ± 4.6 |
| <16 years | 9.21 ± 5.0 | 9.64 ± 3.1 | 9.75 ± 3.6 | 8.57 ± 3.1 | 8.96 ± 4.4 | 9.44 ± 5.2 | |
| ≥16 years | 9.27 ± 2.8 | 9.06 ± 2.9 | 9.46 ± 2.3 | 7.83 ± 2.5 | 8.59 ± 4.3 | 9.50 ± 4.3 | |
| P3 NoGo | All | 11.66 ± 4.2 | 11.94 ± 6.0 | 13.13 ± 6.7 | 10.57 ± 4.5 | 10.08 ± 6.7 | 11.10 ± 7.41 |
| <16 years | 11.24 ± 3.5 | 10.76 ± 6.4 | 11.88 ± 8.1 | 9.60 ± 3.0 | 8.48 ± 6.9 | 9.07 ± 8.7 | |
| ≥16 years | 12.17 ± 4.9 | 13.27 ± 5.3 | 14.23 ± 5.3 | 11.77 ± 5.7 | 11.88 ± 6.1 | 12.89 ± 5.8 | |
N2−effect, N2 Go vs. N2 NoGo. All amplitudes reported in μV, mean ± SD.
Mixed model analysis with the reported Event Related Potentials, ERPs, as dependent variables.
| CNV | All | −0.08 (−0.63 to 0.48), | −0.15 (−0.78 to 0.48), |
| <16 years | 0.56 (−0.25 to 1.36), | 0.75 (−0.23 to 1.74), | |
| ≥16 years | −0.86 (−1.55 to −0.18), | −1.01 (−1.74 to −0.28), | |
| Interaction with age group | |||
| N2 Go | All | 0.53 (−0.44 to 1.50), | −0.29 (−1.30 to 0.72), |
| <16 years | 0.73 (−0.56 to 2.03), | −0.57 (−1.83 to 0.70), | |
| ≥16 years | 0.26 (−1.27 to 1.80), | 0.04 (−1.61 to 1.69), | |
| Interaction with age group | |||
| N2 NoGo | All | 0.07 (−1.18 to 1.32), | −1.25 (−2.71 to −0.28), |
| <16 years | 0.89 (−0.99 to 2.76), | −1.45 (−3.34 to 0.44), | |
| ≥16 years | −0.98 (−2.57 to 0.60), | −1.43 (−3.01 to 0.15), | |
| Interaction with age group | |||
| N2−effect | All | 0.46 (−0.47 to 1.39), | 1.21 (0.17 to 2.24), |
| <16 years | −0.15 (−0.39 to 1.08), | 0.88 (−0.58 to 2.34), | |
| ≥16 years | 1.24 (−0.18 to 2.67), | 1.47 (0.07 to 3.01), | |
| Interaction with age group | |||
| Cue P3 | All | 0.43 (−0.56 to 1.42), | 0.23 (−0.80 to 1.26), |
| <16 years | 0.22 (−1.15 to 1.59), | −0.11 (−1.69 to 1.47), | |
| ≥16 years | 0.78 (−0.63 to 2.19), | 0.42 (−0.92 to 1.76), | |
| Interaction with age group | |||
| P3 Go | All | 0.34 (−0.98 to 1.67), | 0.92 (−0.62 to 2.46), |
| <16 years | 0.32 (−1.63 to 2.28), | 0.43 (−2.15 to 3.02), | |
| ≥16 years | 0.45 (−1.30 to 2.22), | 1.21 (−0.51 to 2.93), | |
| Interaction with age group | |||
| P3 NoGo | All | −0.08 (−2.16 to 1.99), | 1.11 (−1.35 to 3.57), |
| <16 years | −0.95 (−3.68 to 1.77), | −0.27 (−3.95 to 3.41), | |
| ≥16 years | 1.16 (−1.92 to 4.25), | 2.16 (−1.15 to 5.47), | |
| Interaction with age group |
N2-effect, N2 Go vs. N2 NoGo.
Significant at the 0.05 level (2-tailed).
Significant at the 0.01 level (2-tailed). The fixed effects were diagnostic group [typically developing (TD) vs. autism spectrum disorder (ASD)], task (VCPT vs. ECPT) and gender. We first analyzed using the whole sample, then separately for each age group. We then included the interaction between age group and diagnostic group. The analyses were finally recomputed for the groups TD vs. ASD without comorbid ADHD (ASD–ADHD).
Figure 3Box plot of Contingent Negative Variation, CNV, in VCPT/ECPT. Mean CNV VCPT and ECPT increases from young to old in TD, decreases in ASD, giving a significant age-group × diagnosis interaction.
Figure 4Contingent negative variation, CNV, in VCPT/ECPT vs. age in typical developing adolescents (TD) and adolescents with autism spectrum disorders (ASD). Scatterplots with loess curves fitted to each diagnostic group.